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INTRODUCTION
The prevalence of neuropathic pain is estimated to 
be 6.9-10％ worldwide 1）. Only 15-50％ of patients 
with neuropathic pain exhibit mechanical allodynia 2）, 
while almost 100％ of patients struggle with spontane-
ous pain 3）. Despite that the neuropathic pain can be a 
major burden, the current treatments include pharma-
cotherapy, physical therapy, cognitive therapy, inter-
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SUMMARY
Purpose：Several studies investigated the efficacy of transplanting adipose-derived mesenchymal stem 
cells（ADMSCs）in the treatment of neuropathic pain in animals. However, these studies evaluated the 
effects of ADMSCs transplantation by assessing the mechanical allodynia but not spontaneous pain. Here, 
we verify whether ADMSCs transplantation improves spontaneous pain in a rat model of neuropathic pain.
Methods：ADMSCs were isolated from rat adipose tissue and cultured. Chronic constriction injury（CCI）
model rats were created by surgical maneuver. A total of 20 F344 rats underwent surgery and were 
divided into 2 groups, the ADMSCs group and the control group. One week after CCI surgery, ADMSCs 
were transplanted into the epineurium of the damaged nerve. The effects of ADMSCs transplantation were 
evaluated by the number of spontaneous pain-related behaviors and the degree of mechanical allodynia. 
The degree of mechanical allodynia was assessed with the von-Frey filament test.
Results：No rats died during the experiments and all CCI model rats were established successfully. 
ADMSCs transplantation improved mechanical allodynia on and after 7-day post-transplantation and spon-
taneous pain on and after 21-day post-transplantation with the statistically significant differences. These 
improvement effects were observed until 6-week post-transplantation in mechanical allodynia and 5-week 
post-transplantation in spontaneous pain.
Conclusion：ADMSCs transplantation improved not only mechanical allodynia but also spontaneous pain. 
ADMSCs transplantation may be an effective treatment for neuropathic pain in clinical practice.
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ventional pain management, and other treatments that 
are still insufficient 4,5）. Recently, the effects of the mes-
enchymal stem cells（MSCs）transplantation as the 
treatment for neuropathic pain were examined and 
verified 6,7）. In animal experiments, MSCs transplanta-
tion was shown to improve mechanical allodynia in 
neuropathic pain through their anti-inflammatory and 
immunomodulatory properties 8）. Various types of 
MSCs exist such as bone marrow derived MSCs, adi-
pose-derived MSCs（ADMSCs）, and umbilical cord-
derived MSCs. ADMSCs are advantageous for clinical 
applications because they can be obtained less inva-
sively and in large quantities compared to other 
MSCs types. While several studies examined the 
effects of ADMSCs transplantation for the treatment 
of neuropathic pain 9〜12）, these studies evaluated that 
effects by assessing mechanical allodynia but not 
spontaneous pain. Methods to evaluate mechanical 
allodynia in animal experiments are similar to those 
used for mechanical allodynia evaluation in clinical 
practice. For example, the von-Frey filament test 
used in animal experiments is also used to assess 
mechanical allodynia in humans 13）.
As mentioned above, almost all patients with neuro-
pathic pain have spontaneous pain. Evaluating sponta-
neous pain improvement by the treatment in animal 
experiments would be more directly applicable to the 
judgement of the treatments effectiveness for neuro-
pathic pain in human than evaluating mechanical allo-
dynia improvement.
In this study, we hypothesized that the transplanta-
tion of ADMSCs would improve not only mechanical 
allodynia but also spontaneous pain. To verify this 
hypothesis, we transplanted syngeneic ADMSCs into 
the lesions of chronic constriction injury（CCI）model 
rats and assessed its efficacy to the spontaneous pain 
improvement with the method described by Kawasaki 
Yatsugi et a l 14） and to the mechanical a l lodynia 
improvement with the von-Frey filament test.
METHODS
The research protocol was approved by the Animal 
Research Committee of Dokkyo Medical University
（Animal Research Approval Number 1017）. 9-week-
old Male F344 rats weighing 180-220 g（Japan SLC, 
Shizuoka, Japan）were used. The rats were kept indi-
vidually in cages under standard laboratory conditions 
at 23±2℃ and a humidity of 50±10％ with a 12- 
hour light/dark cycle. All animals were weighed once 
a week and checked for health status. The rats were 
acclimated in the cages for at least 1 week before the 
beginning of the experiment.
A block of adipose tissue was removed from F344 
rats those that had not undergone the CCI surgery. 
ADMSCs were isolated from the adipose tissue and 
passaged 2-4 times to prepare for transplantation. 
CCI surgery was performed on 20 rats according to a 
previously described method by Bennett and Xie 15）. 
Rats were randomly assigned to 2 groups：the ADM-
SCs transplantation group and the control group（10 
for each group）. One week after the CCI surgery, the 
ADMSCs transplantation group rats were transplant-
ed with ADMSCs into the epineurium of the lesions. 
The control group rats were only injected with phos-
phate buffered saline（PBS）into the epineurium of the 
lesions. Spontaneous pain and mechanical allodynia 
were evaluated before ADMSC transplantation and 
then weekly until week 6 of post-transplantation. All 
experiments were performed between 10：00 and 
2 0：00 . The detai ls of each of these steps are 
described below.
Isolation and culture of ADMSCs
Adipose tissue was removed from the inguinal and 
abdominal regions of 9-week-old male F344 rats. The 
tissue was thoroughly washed with PBS and then 
blood vessels and connective tissue were removed. 
The tissue was subsequently minced. The minced tis-
sue was added to a solution containing 0.1％ collage-
nase type 1（Sigma, St. Louis, MO, USA）and 0.2％ 
dispase（Sigma）and mixed by shaking at 37℃ for 
60 minutes. Digested tissue was filtered through a 
100 µm filter. The filtrate was centrifuged at 1200 
rpm for 5 minutes. The isolated cell pellet was washed 
with PBS and centrifuged again. A cell suspension 
containing the isolated ADMSCs was cultured in basic 
medium（Dulbecco’s Modified Eagle’s Medium）con-
taining 10％ fetal bovine serum and 2％ penicillin-
streptomycin at 37℃ and 5％ CO2. Cells at passages 
2-4 were used as ADMSCs for transplantation.
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CCI model rats
The CCI surgery was performed as described by 
Bennett and Xie 15）. All animals were anesthetized 
with isoflurane. The fascia between the gluteal mus-
cles and biceps femoris muscle was opened to expose 
the left sciatic nerve. Proximal to the trifurcation of 
the sciatic nerve, four 4/0 chromic gut ligatures were 
loosely tied around the nerve with the intervals of 
1 mm. The ligatures were constricted to approximate-
ly a third of the diameter of the nerve. The fascia and 
skin were closed with 4/0 nylon thread.
ADMSCs transplantation
ADMSCs were transplanted 7 days after the CCI 
surgery. All animals were anesthetized with isoflu-
rane. To avoid additional nerve damage, the previous 
scar was carefully reopened to expose the sciatic 
nerve. Under microscopic magnification, 1.0×106 cells 
mixed with 50 µL of PBS were transplanted into the 
epineurium with a 32G needle. In the control group, 
50 µL of PBS was injected into the epineurium. The 
fascia and skin were closed with 4-0 nylon thread.
Assessment of spontaneous pain by automatically mea-
suring the number of limb movements including spon-
taneous pain-related behaviors14）
This assessment was performed according to the 
method previously proposed by Kawasaki-Yatsugi et 
al 14）. Magnets were implanted at the timing of CCI 
surgery. A Teflon-coated columnar magnet（1 mm in 
diameter, 3 mm long；SCT-MAG-TF, Neuroscience 
Inc., Tokyo, Japan）was implanted under the dorsal 
skin of the ipsilateral foot. A test chamber surrounded 
by a coil（NS-SCT10R, Neuroscience Inc., Tokyo, 
Japan）was installed in a dim room at constant tem-
perature（23±2℃）. An animal was placed into the 
chamber and given acclimation period of 5 minutes. 
Measurements were conducted for 30 minutes per 
day. Any movements of the magnet-implanted limb 
including abnormal behaviors related to spontaneous 
pain（e.g. lifting and licking the CCI limb）caused the 
changes in the electromagnetic field and generated a 
voltage, the amount of which was dependent on the 
speed and direction of magnet movement. The voltage 
generated in the coil was amplified and digitized via 
an interface unit（NS-SCTB16, Neuroscience Inc., 
Tokyo, Japan）. Abnormal behaviors were automatical-
ly detected as spike waveforms, and counted by ana-
lytical software（MicroAct®；NS-SC-S100, Neurosci-
ence Inc., Tokyo, Japan）. The followings were set as 
analytical parameters for waveforms formed by move-
ment of the limbs：range of frequency 2 .5-20 Hz, 
threshold 0 .01 V, minimum duration 0 .09 seconds, 
shortest duration gap 0.03 seconds.
Quantification of the degree of mechanical allodynia 
using the von-Frey filament test
Mechanical allodynia was evaluated by the up-
down method using von-Frey filaments according to 
the previously described method by Chaplan et al 16）. 
An animal was placed in a plastic box with a metal 
mesh floor. After the adaptation period of 30 minutes, 
a filament was applied perpendicular to the sole of the 
ipsilateral limb with the pressure by which the fila-
ment was slightly bent. Withdrawal of CCI limb upon 
stimuli was regarded as a positive response. Eight fila-
ments（0.4, 0.6, 1.0, 2.0, 4.0, 6.0, 8.0, and 15.0 g）were 
used. The 2.0 g filament was used first. When a posi-
tive response was observed, the next weaker filament 
was used for st imulat ion；if no response was 
observed, the next stronger filament was used. Two 
consecutive stimulations in which an animal’s reaction 
changed from negative to positive or from positive to 
negative was defined as the first 2 reactions, after 
which 4 stimulations were consecutively applied based 
on the animal response. In cases where continuous 
positive and negative response were observed to the 
exhaustion of the filament set, values of 0.25 g and 
15.0 g were applied respectively. According to the 
reaction pattern to these 6 stimulations, the 50％ reac-
tion threshold was calculated by the formula 16）.
Statistical analysis
The number of limb movements including abnormal 
behaviors and the reaction threshold in the von-Frey 
filament test are reported as the mean±standard 
error of the mean（SEM）. Statistical analyses were 
performed using split-plot analysis of variance. 
Unpaired t-test was used as a post-hoc test. SPSS 
version 24（GraphPad Software, Inc., La Jolla, CA, 
USA）was used for all analyses. P values less than 
0.05 were considered statistically significant.
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RESULTS
All the CCI model rats displayed “normal move-
ments” associated with walking and “abnormal move-
ments” including lifting/guarding, flinching/shaking, 
and licking. The number of limb movements in the 
ADMSCs transplantation group（344±53）and in the 
control group（354±36）, after CCI surgery and before 
ADMSCs transplantation or PBS injection, increased 
compared to that of 10 syngeneic rats without CCI 
surgery（80.5±11.6）with the statistical significance. 
The reaction threshold in the ADMSCs transplanta-
tion group（3.70±0.62）and in the control group（4.19
±0.4）, after CCI surgery and before ADMSCs trans-
plantation or PBS injection, decreased compared to 
that of 10 syngeneic rats without CCI surgery（14.19
±0.54）with the statistical significance. Unpaired 
t-test was used to check the result of CCI surgery.
Those changes indicated that the CCI model rats 
were successfully established. No animals died during 
the experiments. All animals kept gaining weight over 
time even after the CCI surgery and ADMSCs trans-
plantation.
Assessment of spontaneous pain
The number of limb movements in the ADMSCs 
transplantation group and the control group were as 
shown in Fig. 1 . Measurements were performed 
before ADMSCs transplantation and on 7-, 14-, 21-, 
28-, 35-, and 42-day post-transplantation. Split-plot 
analysis of variance showed no interaction between 
measurement timing and groups and showed a statis-
tically significant difference in the number of limb 
movements between the ADMSCs transplantation 
group and the control group（p＝0.036）. It suggested 
that statistically significant differences were observed 
between transplantation group and control group, 
irrespective of measurement timing. Unpaired t-test 
was performed as a post-hoc test. This analysis 
showed significant differences between the ADMSCs 
transplantation group and the control group on 21-, 
28-, and 35-day post-transplantation（all of them, p＜
0.05）. These results suggest that ADMSCs transplan-
tation reduced the number of spontaneous pain-relat-
ed behaviors on and after 21-day post-transplanta-
tion.
Quantification of the degree of mechanical allodynia
The reaction threshold in the ADMSCs transplanta-
tion group and the control group were shown in 
Fig. 2. The reaction threshold was evaluated before 
ADMSCs transplantation and on 7-, 14-, 21-, 28-, 
Figure 1　 Effect of adipose-derived mesenchymal stem cells transplantation 
on limb movements including spontaneous pain-related behaviors
All data indicate mean±standard error of the mean. Asterisk（＊）indicates 
statistically different from the control group.
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35-, and 42-day post-transplantation. Split-plot analy-
sis of variance demonstrated an interaction between 
measurement timing and groups. Unpaired t-test as a 
post hoc test detected significant differences on 7-, 
14-, 21-, 28-, 35-, and 42-day post-transplantation（all 
of them, p＜0.05）. These results suggested that ADM-
SCs transplantation alleviated mechanical allodynia on 
and after 7-day post-transplantation.
DISCUSSION
Several studies suggested that ADMSCs transplan-
tation improves neuropathic pain in animal mod-
els 9〜12）. However, these studies evaluated the efficacy 
of ADMSCs transplantation by assessing only 
mechanical allodynia but not spontaneous pain. Murai 
et al. 17）noted differences in the effects of drugs on 
spontaneous and evoked pain-related behaviors in 
rats, and suggested that there are different mecha-
nisms in spontaneous and evoked pain symptoms in 
neuropathic pain condition. Therefore, we think that 
to verify the efficacy of ADMSCs transplantation 
against neuropathic pain in clinical practice, it is perti-
nent to evaluate its efficacy against spontaneous pain, 
even in the animal experiments stage.
The experimental models for neuropathic pain have 
been developed：（1）CCI model of Bennett and 
Xie 15）；（2）the tight ligation of the partial sciatic 
nerve model of the Seltzer et al 18）；and（3）the tight 
ligation of spinal nerves model of Kim and Chung19）. 
All three models mentioned above produce spontane-
ous pain and mechanical allodynia. In this study, we 
used the CCI model as a rat neuropathic pain model, 
because, in the previous studies, the CCI model was 
used to evaluate ADMSCs transplantation effects on 
neuropathic pain 9,11,12）.
We observed an improvement in mechanical allo-
dynia on and after 7-day post-transplantation. This 
result is similar to that of previous studies in which 
ADMSCs were locally transplanted 10,11）. Spontaneous 
pain-related behaviors, however, were significantly 
improved on and after 21-day post-transplantation, 
suggesting that different mechanisms contribute to 
mechanical allodynia and spontaneous pain. It is cur-
rently unknown how ADMSCs improves neuropathic 
pain. In the previous study, ADMSCs administered 
into the subarachnoid space of CCI model rats were 
histologically found on the surface of the spinal cord 
and dorsal root ganglia 11）. These ADMSCs can direct-
ly modulate the inflammatory reactions and immune 
cells, which play important roles in nociception of pain 
and tissue regeneration. It is also suggested that 
MSCs modulate inflammatory and immune processes 
Figure 2　 Effect of adipose-derived mesenchymal stem cells transplantation 
on mechanical allodynia
All data indicate mean±standard error of the mean. Asterisk（＊）indicates 
statistically different from the control group.
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through paracrine release of soluble factors such as 
interleukin 10, leukemia inhibitory factor, and trans-
forming growth factor-b 8）. In addition to these mecha-
nisms, MSCs are known to induce antihyperalgesic 
effects through the activation of the endogenous opi-
oid system. Guo W et al. hypothesized that the activa-
tion of peripheral opioid receptors plays a main role in 
inducing antihyperalgesic effects in the early stages of 
MSC transplantation, while the activation of central 
opioid receptors underlie the antihyperalgesic effects 
in the late stages of MSC transplantation 7）.
While the effectiveness of morphine, an opioid ago-
nist, in the treatment of neuropathic pain had been 
controversial, opioids have been recently used in the 
management of patients with neuropathic pain 20）. In 
CCI model rats, morphine reduced the number of 
spontaneous pain-related behaviors and alleviated 
mechanical allodynia at an s.c. dose of 3 mg/kg or 
greater 17）. However, clinical use of high-dose mor-
phine carries a risk of adverse events including nau-
sea, constipation, sleepiness, sedation, and respiratory 
depression. Given that both MSCs transplantation and 
morphine improve neuropathic pain via modulation of 
the opioid system, our finding that MSCs transplanta-
tion reduced the number of spontaneous pain-related 
behaviors in CCI model rats is not inconsistent with 
theories suggested previously. ADMSCs transplanta-
tion may be a safer therapeutic approach for neuro-
pathic pain than morphine.
Although the safety of autologous MSCs transplan-
tation is controversial, the fact that the number of 
clinical studies using autologous MSCs transplantation 
is increasing 21）, indicating that MSCs transplantation 
techniques satisfy the safety standard in clinical prac-
tice.
All clinical studies using transplantation of the stro-
mal vascular fraction（SVF）and autologous fat for the 
treatment of neuropathic pain 22〜26）have demonstrated 
improvements in spontaneous pain without any major 
complications. We propose that transplantation of cul-
tured ADMSCs, ADMSCs purity of which is higher 
than that of SVF and autologous fat, may be more 
effective for improving pain than transplantation of 
SVF and autologous fat.
This study has some limitations. First, we did not 
examine the effects of intravenous administration of 
ADMSCs for neuropathic pain. The intravenous 
administration of ADMSCs was reported as effective 
to alleviate neuropathic pain 9,11,12）. Second, while we 
verified the inhibitory effect of ADMSCs transplanta-
tion on pain behaviors, we did not examine the histo-
logical or biochemical changes. This study, however, 
demonstrated that ADMSCs transplantation reduced 
the number of spontaneous neuropathic pain-related 
behaviors in a CCI rat model. This new finding may 
suggest that ADMSCs transplantation is effective 
treatment to spontaneous neuropathic pain, which is 
seen in almost all cases of neuropathic pain, in clinical 
practice.
CONCLUSION
The sufficiently effective treatment for the neuro-
pathic pain is not established yet. ADMSCs transplan-
tation emerges as a therapeutic option for the neuro-
pathic pain. We evaluated the effects of ADMSCs 
transplantation on spontaneous pain and mechanical 
allodynia in CCI model rats. In this study, ADMSCs 
transplantation improved not only mechanical allodyn-
ia but also spontaneous pain. A possibility is suggest-
ed that ADMSCs transplantation is effective to 
mechanical allodynia and spontaneous pain of neuro-
pathic pain in clinical practice. Further researches are 
necessary to confirm this possibility.
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